Stryker (SYK) Research & Development (2009 - 2026)

Stryker (SYK) has 18 years of Research & Development data on file, last reported at $413.0 million in Q1 2026.

• Research & Development for Q1 2026 came in at $413.0 million, up 1.98% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.6 billion (up 8.52% YoY), and the FY2025 annual result was $1.6 billion, up 10.71% from the prior year.
• Research & Development advanced to $413.0 million in Q1 2026 per SYK's latest filing, from $401.0 million in the prior quarter.
• Over five years, Research & Development peaked at $413.0 million in Q1 2022 and troughed at $326.0 million in Q4 2022.
• A 5-year average of $373.2 million and a median of $364.0 million in 2022 frame the typical range for Research & Development.
• The sharpest annual moves came in 2022 and 2023: Research & Development surged 43.4% in 2022, then retreated 17.92% in 2023.
• A 5-year view of Research & Development shows it stood at $326.0 million in 2022, then rose by 7.36% to $350.0 million in 2023, then increased by 2.29% to $358.0 million in 2024, then gained by 12.01% to $401.0 million in 2025, then grew by 2.99% to $413.0 million in 2026.
• Business Quant data shows SYK's Research & Development at $413.0 million in Q1 2026, $401.0 million in Q4 2025, and $410.0 million in Q3 2025.